ClinConnect ClinConnect Logo
Search / Trial NCT05810220

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

Launched by NYU LANGONE HEALTH · Mar 30, 2023

Trial Information

Current as of June 03, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how people with hearing impairments process sounds when using cochlear implants or auditory brainstem implants (ABIs). Researchers want to learn more about how these devices help improve hearing and understanding of sounds in both adults and children. By participating in this study, individuals will undergo various tests to evaluate their hearing abilities and how their brains respond to sounds.

To be eligible for this trial, participants should be at least 2 years old and currently use either a cochlear implant or an ABI. It's important that they do not have any other communication or cognitive disorders, and that their implant devices work properly without causing discomfort. If you or a loved one meets these criteria, participating in this research could provide valuable insights into hearing technology and potentially benefit the hearing-impaired community.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Hearing impaired adult and or child (above 2 years old) who uses ABIs or cochlear implants.
  • No diagnosis of any other communicative or cognitive disorder other than hearing impairment. The individual must be able to visit the lab in order to participate in behavioral and electrophysiological experiments.
  • Patients' implant device must have useable electrodes that do not result in uncomfortable or unpleasant non-auditory sensation.
  • Exclusion Criteria:
  • Diagnosed cognitive or communicative disorders (other than hearing impairment)
  • Severe neurological disorders
  • No useable electrodes in their implants

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Mahan Azadpour

Principal Investigator

NYU Langone Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials